Verastem, Inc. (VSTM) to Present at 2013 Forbes Global CEO Conference
8/6/2013 7:39:26 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that Christoph Westphal, M.D., Ph.D., Verastem Executive Chairman, will present this summer at the 2013 Forbes Global CEO Conference (www.forbesasiaconferences.com). Now in its 13th year, the Forbes Global CEO Conference will be held from September 3 - 5, 2013.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by